Detection of cannabinoid receptor biomarkers and uses thereof

Details Detection of cannabinoid receptor biomarkers and uses thereof Detection of cannabinoid receptor biomarkers and uses thereof

2007-04-20

2009-11-03

Ulm, John D (Department: 1649)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C530S350000, C530S324000

Reexamination Certificate

active

07611858

ABSTRACT:
Traumatic insult to the brain leads to a degradation of low molecular weight of cannabinoid type 1 receptor (CB1) and generation of high molecular weight complexes in the cortex and hippocampus, as assessed by both N-terminal and C-terminal specific antibodies. The formation and release of CB1 oligomers was dramatically increased into CSF within 1 hour following traumatic brain insult. Novel CB1 receptor-based, prognostic markers of traumatic brain injury and other forms of brain injury are disclosed. A method of repopulating damaged neural cells by proliferation of a subgroup of neural progenitor cells is described. Targeting CB1 receptors for therapeutic neuroprotection in TBI is also disclosed.

REFERENCES:
patent: 4366241 (1982-12-01), Tom et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4517288 (1985-05-01), Giegel et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4837168 (1989-06-01), de Jaeger et al.
patent: 5030015 (1991-07-01), Baker et al.
patent: 5045694 (1991-09-01), Beavis et al.
patent: 5118937 (1992-06-01), Hillenkamp et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5427908 (1995-06-01), Dower et al.
patent: 5516637 (1996-05-01), Huang et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5580717 (1996-12-01), Dower et al.
patent: 5658727 (1997-08-01), Barbas et al.
patent: 5698426 (1997-12-01), Huse
patent: 5719060 (1998-02-01), Hutchens et al.
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5750753 (1998-05-01), Kimae et al.
patent: 5780225 (1998-07-01), Wigler et al.
patent: 5792664 (1998-08-01), Chait et al.
patent: 5821047 (1998-10-01), Garrard et al.
patent: 5969108 (1999-10-01), McCafferty et al.
patent: 6225047 (2001-05-01), Hutchens et al.
patent: WO 90/02809 (1990-03-01), None
patent: WO 91/10737 (1991-07-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/18619 (1992-10-01), None
patent: WO 93/11236 (1993-06-01), None
patent: WO 93/24834 (1993-12-01), None
patent: WO 95/15982 (1995-06-01), None
patent: WO 95/20401 (1995-08-01), None
patent: WO 99/51773 (1999-10-01), None
patent: WO 00/04389 (2000-01-01), None
patent: WO 00/56934 (2000-09-01), None
Hansen et al., Journal of Neurochemistry, 78(6):1415-1427, 2001.
Sa{hacek over (n)}udo-Pe{hacek over (n)}a et al., Acta Pharmacologica Sinica, 20(12):1115-1120, Dec. 20, 1999.
Wager-Miller et al., Chemistry and Physics of Lipids, 121(1-2):83-89, Dec. 2002.

Affiliated with

Also associated with

Rating

Detection of cannabinoid receptor biomarkers and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection of cannabinoid receptor biomarkers and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of cannabinoid receptor biomarkers and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4126606